Avid Bioservices logo

Avid Bioservices

Brand · Pharmaceutical Manufacturing

3.1

Company overview

Avid Bioservices is a biologics CDMO and partner focused on delivering quality, speed, and predictability from DNA to CGMP.We support biotech and pharma companies across the full development lifecycle, with integrated capabilities in cell line development, process development, and CGMP manufacturing for clinical and commercial supply.Our platforms are intentionally aligned from early development through manufacturing, enabling seamless tech transfer and reducing risk as programs scale.Our approach is built on predictable delivery. We combine rapid timelines with disciplined execution, giving our partners confidence in both speed and outcomes.With transparent communication and strong program management, our teams operate as an extension of our clients - ensuring clarity, accountability, and momentum at every stage.Quality underpins everything we do. We have a strong regulatory track record and a commitment to operational excellence that enables consistent, reliable results from early-phase programs through commercial production. Our U.S.-based facilities provide a trusted, scalable manufacturing environment.At Avid, our services are designed to solve a single problem: how to move biologics programs forward quickly and reliably without compromising quality. By aligning our capabilities, platforms, and teams around that goal, we help our partners accelerate development and deliver therapies to patients with confidence.
Founded in 2002
Tustin, California, USA
397 employees (6 in marketing)
55% recommend to a friend
68% positive business outlook

Salaries

Typical salary range

$204,800 – $256,000

/ yr

Help build salary transparency at Avid Bioservices

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +17.1% year over year

Funding

Total funding

$285M

Last raise

Private Equity, 2 years ago

Funding history

Nov 2024

Private Equity Round Avid Bioservices

Mar 2024

Post IPO Debt Avid Bioservices · $160M

Mar 2021

Post IPO Debt Avid Bioservices · $125M

Audience

Monthly website visitors
13.1K
Month over month-32.6%
Quarter over quarter+57.8%
Top sourceSearch (51.8%)
Ad budget per month$7.8K
Average search rank36.5
Traffic source mix
Search
51.8%
Referral
26.4%
Direct
15.1%
Social
3%
Paid referral
1%

LinkedIn followers

Follower count and growth

Total followers

12.9K

12-mo growth

+42.5%

Monthly growth

+1.3%

News

Links